2-Amino-7-substituted benzoxazole analogs as potent RSK2 inhibitors
Abran Costales(Novartis (Switzerland)), Cynthia M. Shafer(Novartis (Switzerland)), Stephen E. Basham(Therapeutics Clinical Research), Mika Lindvall, Savithri Ramurthy(FuelCell Energy (United States)), Michelle Mathur, Paul Feucht(Novartis (United States)), Gordana Atallah, Elizabeth Ornelas, B.A. Appleton(Novartis (Switzerland)), Ida Aronchik(Revolution Medicines (United States)), Jiong Lan(Novartis (Switzerland)), Sharadha Subramanian(Novartis (Switzerland)), Rama Jain, Anne B. Jefferson, Laura V. Doyle, L Setti, Bob Warne
Cited by 28
Related Papers
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction
|Nature Communications|2019|213
Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers
|Clinical Cancer Research|2014|111
Neonatal Development of the Stratum Corneum pH Gradient: Localization and Mechanisms Leading to Emergence of Optimal Barrier Function
|Journal of Investigative Dermatology|2003|97
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
|Journal of Medicinal Chemistry|2015|84
Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven Cancers
|Molecular Cancer Research|2014|80